$70M US alliance to develop new cell therapies for blinding eye diseases building on FBC funded research
A new strategic research and development (R&D) alliance was announced on May 17, 2021 between BlueRock Therapeutics LP, FUJIFILM Cellular Dynamics Inc (FCDI) and Opsis Therapeutics LLC to develop new cell therapies…
New report reveals vision loss costs Canada almost $33 billion annually
Fighting Blindness Canada, partnering with the Canadian Council of the Blind and key partners, the Canadian Association of Optometrists and the Canadian Ophthalmological Society, commissioned new research, The Cost of Vision loss…
FBC announces new award to fund BBS10 research
Fighting Blindness Canada (FBC) is pleased to announce a new award to support research by Dr. Arlene Drack (University of Iowa) to develop a new gene therapy treatment for retinal degeneration caused…
Other Eye Diseases
Adult REFSUM DISEASE Adult Refsum disease (ARD) is a rare inherited disease where a fat called phytanic acid builds up in the body, leading to different symptoms. The most common first sign…
New FBC award to uncover links between inflammation and Stargardt disease
Fighting Blindness Canada (FBC) is pleased to announce funding for a new research award focused on Stargardt disease. Dr. Bob Chow (University of Victoria) will be leading the project to understand the…
Join the Fight!
Learn how your support is helping to bring a future without blindness into focus! Be the first to learn about the latest breakthroughs in vision research and events in your community by subscribing to our e-newsletter that lands in inboxes the beginning of each month.
